Braun Jerry, van de Veire Nico R, Klautz Robert J M, Versteegh Michel I M, Holman Eduard R, Westenberg Jos J M, Boersma Eric, van der Wall Ernst E, Bax Jeroen J, Dion Robert A E
Department of Cardiothoracic Surgery, Leids Universitair Medisch Centrum, Leiden, The Netherlands.
Ann Thorac Surg. 2008 Feb;85(2):430-6; discussion 436-7. doi: 10.1016/j.athoracsur.2007.08.040.
Restrictive mitral annuloplasty with revascularization is considered the best approach to ischemic mitral regurgitation with heart failure, but late results are controversial. We report late outcome in relation to preoperative left ventricular end-diastolic diameter (LVEDD) cutoff values, previously identified to predict intermediate-term left ventricular reverse remodeling.
One hundred consecutive ischemic mitral regurgitation patients underwent restrictive mitral annuloplasty (stringent downsizing by two ring sizes; median size, 26) and coronary revascularization. Survivors were clinically and echocardiographically assessed at intermediate (18 months) and late (mean, 46 months) follow-up.
Early mortality was 8%, and late mortality was 18%. Actuarial 1-, 3-, and 5-year survival rates were 87% +/- 3.4%, 80% +/- 4.1%, and 71% +/- 5.1%. Mortality predictors (Cox regression) were preoperative inotropic support (hazard ratio, 6.2; 95% confidence interval, 2.3 to 16.9) and preoperative LVEDD greater than 65 mm (hazard ratio, 4.5; 95% confidence interval, 1.9 to 10.9). Five-year survival rate for patients with LVEDD of 65 mm or less was 80% +/- 5.2%, versus 49% +/- 11% for LVEDD greater than 65 mm (p = 0.002). At 4.3 years' follow-up, New York Heart Association functional class had improved from 2.9 +/- 0.8 to 1.6 +/- 0.6 (p < 0.01). Mitral regurgitation grade was 0.8 +/- 0.7, and was less than grade 2+ in 85% of patients. Left ventricular reverse remodeling was sustained with time for the LVEDD of 65 mm or less group. Late deaths did not show intermediate-term systolic left ventricular reverse remodeling, indicating a more extensive intrinsic left ventricular abnormality.
At 4.3 years' follow-up, intermediate-term cutoff values for left ventricular reverse remodeling proved to be predictors for late mortality. For patients with preoperative LVEDD of 65 mm or less, restrictive mitral annuloplasty with revascularization provides a cure for ischemic mitral regurgitation and heart failure; however, when LVEDD exceeds 65 mm, outcome is poor and a ventricular approach should be considered.
限制性二尖瓣环成形术联合血运重建被认为是治疗缺血性二尖瓣反流伴心力衰竭的最佳方法,但远期疗效仍存在争议。我们报告了与术前左心室舒张末期直径(LVEDD)临界值相关的远期结果,该临界值先前已被确定可预测中期左心室逆向重构。
连续100例缺血性二尖瓣反流患者接受了限制性二尖瓣环成形术(严格缩小两个环尺寸;中位尺寸为26)和冠状动脉血运重建。对幸存者在中期(18个月)和远期(平均46个月)随访时进行临床和超声心动图评估。
早期死亡率为8%,晚期死亡率为18%。1年、3年和5年的精算生存率分别为87%±3.4%、80%±4.1%和71%±5.1%。死亡预测因素(Cox回归)为术前使用正性肌力药物支持(风险比,6.2;95%置信区间,2.3至16.9)和术前LVEDD大于65mm(风险比,4.5;95%置信区间,1.9至10.9)。LVEDD为65mm或更小的患者5年生存率为80%±5.2%,而LVEDD大于65mm的患者为49%±11%(p = 0.002)。在4.3年的随访中,纽约心脏协会心功能分级从2.9±0.8改善至1.6±0.6(p < 0.01)。二尖瓣反流分级为0.8±0.7,85%的患者反流程度小于2+级。LVEDD为65mm或更小的组左心室逆向重构随时间持续存在。晚期死亡患者未显示中期左心室收缩期逆向重构,表明存在更广泛的左心室内在异常。
在4.3年的随访中,中期左心室逆向重构的临界值被证明是晚期死亡率的预测指标。对于术前LVEDD为65mm或更小的患者,限制性二尖瓣环成形术联合血运重建可治愈缺血性二尖瓣反流和心力衰竭;然而,当LVEDD超过65mm时,预后较差,应考虑采用心室手术方法。